VA

Vandana Anand

Active Director Director DIN 08616602
DIN 08616602 First appointment Nov 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2019
Shareholding value •••• Premium profile

About Vandana Anand

Data last updated:

Vandana Anand is a Director at Sneh Biotech Private Limited (since 2019). The company operates in Healthcare. Sneh Biotech Private Limited reported revenue of ₹70.24 Cr (FY 2024).

DIN 08616602
Primary Designation Director
Industry Healthcare
First Appointment 20 Nov 2019
Oldest Company Age 6 yrs
Largest company Sneh Biotech Private Limited · ₹70.24 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sneh Biotech Private Limited U51909DL2019PTC357752
Director20 Nov 20192019₹70.24 Cr (FY 2024)Active

Board colleagues of Vandana Anand

NameDINCompanyDesignation
Vinay Anand08616633Sneh Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sneh Biotech Private Limited
Premium access

Shareholding and investment profile for Vandana Anand

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vandana Anand

Vandana Anand currently holds 1 directorship: Sneh Biotech Private Limited (Director, since 20 Nov 2019, revenue ₹70.24 Cr (FY 2024)).

Vandana Anand was first appointed on 20 Nov 2019 as Director at Sneh Biotech Private Limited.

The current boards of Vandana Anand's companies include Vinay Anand (Sneh Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available